Study Comparing Tutomesh® Repair to Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction
Launched by CENTRE HOSPITALIER RÉGIONAL UNIVERSITAIRE MONTPELLIER · Feb 22, 2010
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient presenting with an incisional hernia or complicated hernia contraindicating the use of non absorbable mesh:
- • Infected incisional hernia: abdominal wall abscess, chronic fistula
- • Incisional hernia with high septic potential: incisional hernia with strangulation of one or more intestinal loops, repair of incisional hernia during surgery requiring opening of the digestive tube (digestive resection, restoration of digestive continuity, gastro-intestinal perforation, peritonitis from digestive origin)
- • Recurrent incisional hernia with problem of cutaneous healing
- • Incisional hernia requiring important intestinal adhesiolysis
- • Patients signing informed consent form after reading and understanding the information letter _ Patients are more than 18 year old
- Exclusion Criteria:
- • Patient with major anesthetic risk (ASA 4)
- • Patient suffering from immunodepression or under immunosuppressor treatment (corticoids...)
- • Patients already enrolled in another study
- • Patient suffering from severe disease not allowing a 1-year follow-up
- • Patient refusing to be enrolled after consulting the information letter
- • Patient presenting with a too large incisional hernia, superior to 140x200 mm
- • Pregnancy
About Centre Hospitalier Régional Universitaire Montpellier
The Centre Hospitalier Régional Universitaire (CHRU) Montpellier is a leading academic hospital located in Montpellier, France, renowned for its commitment to advanced patient care, innovative research, and medical education. As a prominent clinical trial sponsor, CHRU Montpellier actively engages in a wide array of clinical studies across various medical disciplines, striving to enhance therapeutic outcomes and contribute to the body of scientific knowledge. The institution's multidisciplinary approach fosters collaboration among healthcare professionals, researchers, and industry partners, ensuring the implementation of cutting-edge methodologies and adherence to the highest ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Nantes, , France
Toulouse, , France
Marseille, , France
Beziers, , France
Aix En Provence, , France
Antibes, , France
Aubagne, , France
Avignon, , France
Bondy, , France
Fréjus, , France
Grenoble La Tronche, , France
Montpellier, , France
Nice, , France
Nimes, , France
Paris, , France
Salon De Provence, , France
Strasbourg, , France
Tours, , France
Patients applied
Trial Officials
David Nocca, Dr
Principal Investigator
University Hospital, Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials